Marginum
Latest round
- Seed
Last raised
- Nov 2023
Total raised
- $1.1M
Investors
- 3
About Marginum
Founded in 2020 and based in Tampere, Finland, Marginum Oy is a medical technology startup that is developing tissue detection systems based on fluorescence. As of 2022, Samu Lehtonen is the CEO of the company. The company offers a real-time operating device that monitors the content of surgical suction fluids based on fluorescence intensity and provides objective and precise feedback to the surgeon if any traces of tumour are present in the resected tissue. The firm also provides data-driven solutions for monitoring tumour tissues during cancer surgery without interfering with pre-existing surgical workflows.
Who invested in Marginum
3 investors across 1 round
See all investors in Marginum
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 5, 2023
Amount
$1.1M
Investors
Questions about Marginum
Who invested in Marginum?
Marginum has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Marginum raised?
Marginum has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Marginum last raise money?
Marginum's most recent round on record is a Seed, in Nov 2023.
What does Marginum do?
Founded in 2020 and based in Tampere, Finland, Marginum Oy is a medical technology startup that is developing tissue detection systems based on fluorescence.
Where is Marginum headquartered?
Marginum is headquartered in Tampere, Finland.
Which VCs invest in companies like Marginum?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Marginum's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Marginum? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.